Benjamin R. Yerxa
President, Director · Opus Genetics, Inc.
- 2024
- Jul 27, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin R. Yerxa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $10.15M in IRD purchases and sales in the last 12 months
- Cam Gallagher - $324K in IRD purchases and sales in the last 12 months
- George Magrath - $205K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Ashwath Jayagopal - $58K in IRD purchases and sales in the last 12 months
- Joseph K. Schachle - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Benjamin R. Yerxa?
Benjamin R. Yerxa is a corporate insider, tracked as President, Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Benjamin R. Yerxa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Benjamin R. Yerxa been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 2 open-market sales ($61K) across all tracked filings.
